Melanin pigmentary disorders: Treatment update

Dermatologic Clinics

Volumn 23, Issue 2, 2005, Pages 209-226

  Ortonne, Jean Paul ^a   Passeron, Thierry ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BETAMETHASONE VALERATE; CALCIPOTRIOL; CLOBETASOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROQUINONE; IMMUNOMODULATING AGENT; KHELLIN; LEVAMISOLE; MELANIN; MEQUINOL; METHISOPRINOL; METHOXSALEN; PHENYLALANINE; PLACEBO; PLACENTA EXTRACT; POLYPODIUM LEUCOTOMOS EXTRACT; PSORALEN; RESORCINOL DERIVATIVE; SELENIUM; STEROID; SUPLATAST TOSYLATE; TACROLIMUS; TOCOPHEROL; TRIAMCINOLONE; UBIQUINONE; UNINDEXED DRUG;

ACNE; AUTOTRANSPLANTATION; BLEACHING; BLISTER; BULLOUS SKIN DISEASE; CELL CULTURE; CELL TRANSPLANTATION; CHLOASMA; CLINICAL TRIAL; CREAM; CRYOTHERAPY; CUSHING SYNDROME; DEPIGMENTATION; DIAGNOSTIC ACCURACY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG POTENCY; DRUG SAFETY; ECCHYMOSIS; EPIDERMIS CELL; ERYTHEMA; ESTHETIC SURGERY; EXCIMER LASER; FLUORESCENT LIGHTING; FOLLOW UP; HISTOLOGY; HUMAN; HYPERPIGMENTATION; HYPOMELANOSIS; HYPOTHALAMUS FUNCTION DISORDER; IONTOPHORESIS; LASER SURGERY; LENTIGO; LEUKODERMA; LIGHT EXPOSURE; LIVER TOXICITY; LOTION; LOW LEVEL LASER THERAPY; MALIGNANT LENTIGO; MELANOCYTE; MELANOGENESIS; NAIL COLOR DEFECT; NAUSEA; NEPHROTIC SYNDROME; OCHRONOSIS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PHOTOTOXICITY; PIGMENT DISORDER; POIKILODERMA; PRIORITY JOURNAL; PRURITUS; PUNCH BIOPSY; PUVA; RADIATION DOSE; REVIEW; ROSACEA; SCAR FORMATION; SIDE EFFECT; SKIN ABRASION; SKIN ALLERGY; SKIN ATROPHY; SKIN DISEASE; SKIN EXAMINATION; SKIN IRRITATION; SKIN PIGMENTATION; SPLIT THICKNESS SKIN GRAFT; STATISTICAL SIGNIFICANCE; STRIA; SUN EXPOSURE; SURGICAL TECHNIQUE; TELANGIECTASIA; TINEA VERSICOLOR; TREATMENT WITHDRAWAL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; VITILIGO; XEROSIS;

EID: 17044388555     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2005.01.001     Document Type: Review

References (99)

1. J.P. Ortonne, and J.J. Nordlund The pigmentary system: physiology and physiopathology 1998 Oxford University Press New York
2. J.V. Schaffer, and J.L. Bolognia The treatment of hypopigmentation in children Clin Dermatol 21 2003 296 310
3. P.E. Grimes Psoralen photochemotherapy for vitiligo Clin Dermatol 15 1997 921 926
4. M.D. Njoo, P.I. Spuls, and J.D. Bos Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature Arch Dermatol 134 1998 1532 1540
5. W. Koster, and A. Wiskemann Phototherapy with UV-B in vitiligo Z Hautkr 65 1990 1022 1029
6. M.E. Mofty, H. Zaher, and S. Esmat PUVA and PUVB in vitiligo: are they equally effective? Photodermatol Photoimmunol Photomed 17 2001 159 163
7. J.P. Ortonne Vitiligo and other disorders of hypopigmentation J.L. Bolognia Dermatology, vol. I, chapter 66 2003 Mosby New York 947 973
8. J.J. Nordlund, and J.P. Ortonne Vitiligo vulgaris J.J. Nordlund The pigmentary system. chapter 37 1998 Oxford University Press New York 513 550
9. K.U. Schallreuter, J.M. Wood, and K.R. Lemke Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients Dermatology 190 1995 223 229
10. T. Lotti, G. Menchini, and L. Andreassi UV-B radiation microphototherapy: an elective treatment for segmental vitiligo J Eur Acad Dermatol Venereol 13 1999 102 108
11. G. Menchini, E. Tsoureli-Nikita, and J. Hercogova Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo J Eur Acad Dermatol Venereol 17 2003 171 177
12. G. Leone, P. Iacovelli, and A. Paro Vidolin Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study J Eur Acad Dermatol Venereol 17 2003 531 537
13. J.M. Spencer, R. Nossa, and J. Ajmeri Treatment of vitiligo with the 308-nm excimer laser: a pilot study J Am Acad Dermatol 46 2002 727 731
14. E. Baltas, Z. Csoma, and F. Ignacz Treatment of vitiligo with the 308-nm xenon chloride excimer laser Arch Dermatol 138 2002 1619 1620
15. A. Taneja, M. Trehan, and C.R. Taylor 308-nm excimer laser for the treatment of localized vitiligo Int J Dermatol 42 2003 658 662
16. M. Esposito, R. Soda, and A. Costanzo Treatment of vitiligo with the 308 nm excimer laser Clin Exp Dermatol 29 2004 133 137
17. N. Ostovari, T. Passeron, and W. Zakaria Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response Lasers Surg Med 35 2004 152 156
18. M.R. Alexiades-Armenakas, L.J. Bernstein, and P.M. Friedman The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba Arch Dermatol 140 2004 955 960
19. D.A. Smith, S.J. Tofte, and J.M. Hanifin Repigmentation of vitiligo with topical tacrolimus Dermatology 205 2002 301 303
20. P.E. Grimes, T. Soriano, and M.T. Dytoc Topical tacrolimus for repigmentation of vitiligo J Am Acad Dermatol 47 2002 789 791
21. V. Lepe, B. Moncada, and J.P. Castanedo-Cazares A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo Arch Dermatol 139 2003 581 585
22. W. Westerhof, L. Nieuweboer-Krobotova, and P.G. Mulder Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo Arch Dermatol 135 1999 1061 1066
23. A. Hartmann, C.L. Henning Hamm, and E.B. Bröcker Narrow-band UVB 311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo Int J Dermatol 2004 [Online publication]. Available at: http://blackwell-synergy.com
24. J.P. Castanedo-Cazares, V. Lepe, and B. Moncada Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band Photodermatol Photoimmunol Photomed 19 2003 35 36
25. T. Passeron, N. Ostovari, and W. Zakaria Topical tacrolimus and 308 nm excimer laser: a synergistic combination for the treatment of vitiligo Arch Dermatol 140 2004 1291 1293
26. A.Z. Kawelek, J.M. Spencer, and R.G. Phelps Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study Dermatol Surg 30 2004 130 135
27. E.A. Tanghetti, and P.R. Gillis Clinical evaluation of B clear and protopic treatment for vitiligo Lasers Surg Med 32 2003 37
28. A. Hartmann, E.B. Brocker, and J.C. Becker Hypopigmentary skin disorders: current treatment options and future directions Drugs 64 2004 89 107
29. M.D. Njoo, W. Westerhof, and J.D. Bos A systematic review of autologous transplantation methods in vitiligo Arch Dermatol 134 1998 1543 1549
30. M. Yaar, and B.A. Gilchrest Vitiligo: the evolution of cultured epidermal autografts and other surgical treatment modalities Arch Dermatol 137 2001 348 349
31. R. Falabella Surgical therapies for vitiligo Clin Dermatol 15 1997 927 939
32. L. Guerra, S. Capurro, and F. Melchi Treatment of stable vitiligo by timed surgery and transplantation of cultured epidermal autografts Arch Dermatol 136 2000 1380 1389
33. W. Westerhof, and B. Boersma The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation J Am Acad Dermatol 33 1995 1061 1062
34. R. Falabella, A. Arrunategui, and M.I. Barona The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation J Am Acad Dermatol 32 1995 228 232
35. G.Y. Na, S.K. Seo, and S.K. Choi Single hair grafting for the treatment of vitiligo J Am Acad Dermatol 38 1998 580 584
36. T.W. McGovern, J. Bolognia, and D.J. Leffell Flip-top pigment transplantation: a novel transplantation procedure for the treatment of depigmentation Arch Dermatol 135 1999 1305 1307
37. Y. Gauthier, and J.E. Surleve-Bazeille Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions J Am Acad Dermatol 26 1992 191 194
38. M.J. Olsson, and L. Juhlin Melanocyte transplantation in vitiligo Lancet 340 1992 981
39. M.J. Olsson, and L. Juhlin Clinical findings and therapeutic methods in vitiligo: patient's own melanocytes produce new pigmentation Lakartidningen 92 1995 1341 1344
40. R. Falabella, C. Escobar, and I. Borrero Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes J Am Acad Dermatol 26 1992 230 236
41. R. Kaufmann, D. Greiner, and S. Kippenberger Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo Acta Derm Venereol 78 1998 136 138
42. H. Zachariae, C. Zachariae, and B. Deleuran Autotransplantation in vitiligo: treatment with epidermal grafts and cultured melanocytes Acta Derm Venereol 73 1993 46 48
43. M.J. Olsson, G. Moellmann, and A.B. Lerner Vitiligo: repigmentation with cultured melanocytes after cryostorage Acta Derm Venereol 74 1994 226 228
44. R.M. Halder, H.N. Pham, and J.Y. Breadon Micropigmentation for the treatment of vitiligo J Dermatol Surg Oncol 15 1989 1092 1098
45. D.B. Mosher, J.A. Parrish, and T.B. Fitzpatrick Monobenzylether of hydroquinone: a retrospective study of treatment of 18 vitiligo patients and a review of the literature Br J Dermatol 97 1977 669 679
46. M. Silvan The psychological aspects of vitiligo Cutis 73 2004 163 167
47. M.D. Njoo, R.M. Vodegel, and W. Westerhof Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser J Am Acad Dermatol 42 2000 760 769
48. A.J. Stratigos, and A.D. Katsambas Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients Am J Clin Dermatol 5 2004 161 168
49. K. Jimbow, H. Obata, and M.A. Pathak Mechanism of depigmentation by hydroquinone J Invest Dermatol 62 1974 436 449
50. M.C. Spencer Hydroquinone bleaching Arch Dermatol 84 1961 131 134
51. A.D. Katsambas, and A.J. Stratigos Depigmenting and bleaching agents: coping with hyperpigmentation Clin Dermatol 19 2001 483 488
52. S. Briganti, E. Camera, and M. Picardo Chemical and instrumental approaches to treat hyperpigmentation Pigment Cell Res 16 2003 101 110
53. Researching Committee of Rucinol The study on the efficacy of Rucinol (4-N-butylresorcinol) in chloasma Nishinihon J Dermatol 1999 61 66
54. T. Akasaka, H. Ohurazaka, and G. Nishioheda Topically applied 0.3% 4-N-butylresorcinol decrease pigmentation after laser therapy Environ Dermatol 9 2002 11 15
55. S.S. Bleehen The treatment of hypermelanosis with 4-isopropylcatechol Br J Dermatol 94 1976 687 694
56. K. Jimbow N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma Arch Dermatol 127 1991 1528 1534
57. V.M. Verallo-Rowell, V. Verallo, and K. Graupe Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma Acta Derm Venereol Suppl (Stockh) 143 1989 58 61
58. M. Nakagawa, and K. Kawai Contact allergy to kojic acid in skin care products Contact Dermatitis 32 1995 9 13
59. K. Kameyama, C. Sakai, and S. Kondoh Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo J Am Acad Dermatol 34 1996 29 33
60. C.H. Huh, K.I. Seo, and J.Y. Park A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma Dermatology 206 2003 316 320
61. L.E. Espinal-Perez, B. Moncada, and J.P. Castanedo-Cazares A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma Int J Dermatol 43 2004 604 607
62. C.E. Griffiths, L.J. Finkel, and C.M. Ditre Topical tretinoin (retinoic acid) improves melasma: a vehicle-controlled, clinical trial Br J Dermatol 129 1993 415 421
63. C.K. Kimbrough-Green, C.E. Griffiths, and L.J. Finkel Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial Arch Dermatol 130 1994 727 733
64. E.S. Rafal, C.E. Griffiths, and C.M. Ditre Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage N Engl J Med 326 1992 368 374
65. S.M. Bulengo-Ransby, C.E. Griffiths, and C.K. Kimbrough-Green Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients N Engl J Med 328 1993 1438 1443
66. C. Romero, E. Aberdam, and C. Larnier Retinoic acid as modulator of UVB-induced melanocyte differentiation: involvement of the melanogenic enzymes expression J Cell Sci 107 Pt 4 1994 1095 1103
67. J. Sefton, A.M. Kligman, and S.C. Kopper Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel J Am Acad Dermatol 43 2000 656 663
68. S. Kang, M.T. Goldfarb, and J.S. Weiss Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial J Am Acad Dermatol 49 2003 83 90
69. M. Amer, and M. Metwalli Topical liquiritin improves melasma Int J Dermatol 39 2000 299 301
70. T. Yokota, H. Nishio, and Y. Kubota The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation Pigment Cell Res 11 1998 355 361
71. C. Saliou, M. Kitazawa, and L. McLaughlin Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line Free Radic Biol Med 26 1999 174 183
72. H. Ando, A. Ryu, and A. Hashimoto Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin Arch Dermatol Res 290 1998 375 381
73. H. Ando, H. Watabe, and J.C. Valencia Fatty acids regulate pigmentation via proteasomal degradation of tyrosinase: a new aspect of ubiquitin-proteasome function J Biol Chem 279 2004 15427 15433
74. S.C. Taylor, H. Torok, and T. Jones Efficacy and safety of a new triple-combination agent for the treatment of facial melasma Cutis 72 2003 67 72
75. J.P. Ortonne, F. Camacho, and N. Wainwright Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2% /tretinoin 0.01% solution and sunscreen in solar lentigines Cutis 74 4 2004 261 264
76. A.B. Fleischer Jr, E.H. Schwartzel, and S.I. Colby The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies J Am Acad Dermatol 42 2000 459 467
77. K. Graupe, V.M. Verallo-Rowell, and V. Verallo Combined use of 20% azelaic acid cream and 0.05% tretinoin cream in the topical treatment of melasma J Dermatol Treat 7 1996 235 237
78. L.S. Kakita, and N.J. Lowe Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone Clin Ther 20 1998 960 970
79. J.T. Lim Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid Dermatol Surg 25 1999 282 284
80. M.D. Njoo, H.E. Menke, and S. Pavel N-acetyl-cysteine as a bleaching agent in the treatment of melasma: a letter to the editor J Eur Acad Dermatol Venereol 9 1997 86 87
81. A. Mahe, F. Ly, and G. Aymard Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal Br J Dermatol 148 2003 493 500
82. A. Perez-Bernal, M.A. Munoz-Perez, and F. Camacho Management of facial hyperpigmentation Am J Clin Dermatol 1 2000 261 268
83. D.J. Goldberg, and J.G. Meine Treatment of facial telangiectases with the diode-pumped frequency-doubled Q-switched Nd:YAG laser Dermatol Surg 24 1998 828 832
84. J.T. Lim, and S.N. Tham Glycolic acid peels in the treatment of melasma among Asian women Dermatol Surg 23 1997 177 179
85. P.E. Grimes The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups Dermatol Surg 25 1999 18 22
86. S. Kunachak, P. Leelaudomlipi, and S. Wongwaisayawan Dermabrasion: a curative treatment for melasma Aesthetic Plast Surg 25 2001 114 117
87. A.G. Pandya, and I.L. Guevara Disorders of hyperpigmentation Dermatol Clin 18 2000 91 98
88. M.M. Todd, T.M. Rallis, and J.W. Gerwels A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial Arch Dermatol 136 2000 841 846
89. P. Bjerning, and K. Christiansen Intense pulsed light source for treatment of small melanocytic nevi and solar lentigines J Cut Laser Ther 2 2000 177 181
90. A.J. Stratigos, J.S. Dover, and K.A. Arndt Laser treatment of pigmented lesions-2000: how far have we gone? Arch Dermatol 136 2000 915 921
91. Y.T. Li, and K.C. Yang Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines Dermatol Surg 25 1999 202 204
92. C.R. Taylor, and R.R. Anderson Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser J Dermatol Surg Oncol 20 1994 592 597
93. 2 laser followed by Q-switched alexandrite laser: a pilot study Dermatol Surg 25 1999 494 497
94. R.M. Manaloto, and T. Alster Erbium:YAG laser resurfacing for refractory melasma Dermatol Surg 25 1999 121 123
95. S.A. Holme, P.E. Beattie, and C.J. Fleming Cosmetic camouflage advice improves quality of life Br J Dermatol 147 2002 946 949
96. S.B. Levy Tanning preparations Dermatol Clin 18 2000 591 596
97. Y. Suga, A. Ikejima, and S. Matsuba Medical pearl: DHA application for camouflaging segmental vitiligo and piebald lesions J Am Acad Dermatol 47 2002 436 438
98. K. Ongenae, N. Van Geel, and S. De Schepper Management of vitiligo patients and attitude of dermatologists towards vitiligo Eur J Dermatol 14 2004 177 181
99. C.H. Yang, S.C. Shen, and J.C. Lee Seeing the gene therapy: application of gene gun technique to transfect and decolour pigmented rat skin with human agouti signalling protein cDNA Gene Ther 11 2004 1033 1039